Clinical Trials Browser

Phase 2 × Has announcements × Lenalidomide × Clear all

NCT03412565 2025-04-29

A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

Phase 2 Completed

265 enrolled 21 charts 2 FDA

Multiple Myeloma

NCT02399085 2023-10-23

L-MIND

Phase 2 Completed

81 enrolled 23 charts 1 FDA

Lymphoma, Large B-Cell, Diffuse